nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP2C8—Mometasone—systemic scleroderma	0.143	0.211	CbGbCtD
Gemfibrozil—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.135	0.198	CbGbCtD
Gemfibrozil—CYP1A2—Pentoxifylline—systemic scleroderma	0.0748	0.11	CbGbCtD
Gemfibrozil—CYP1A2—Leflunomide—systemic scleroderma	0.0714	0.105	CbGbCtD
Gemfibrozil—CYP2C9—Leflunomide—systemic scleroderma	0.0643	0.0947	CbGbCtD
Gemfibrozil—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.057	0.0839	CbGbCtD
Gemfibrozil—SLCO1B1—Methotrexate—systemic scleroderma	0.054	0.0795	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—systemic scleroderma	0.0382	0.0563	CbGbCtD
Gemfibrozil—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0231	0.034	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—systemic scleroderma	0.0185	0.0272	CbGbCtD
Gemfibrozil—CYP2C9—cardial valve—systemic scleroderma	0.0163	0.411	CbGeAlD
Gemfibrozil—PPARA—blood vessel—systemic scleroderma	0.00593	0.149	CbGeAlD
Gemfibrozil—PPARA—connective tissue—systemic scleroderma	0.00304	0.0764	CbGeAlD
Gemfibrozil—PPARA—smooth muscle tissue—systemic scleroderma	0.00278	0.0699	CbGeAlD
Gemfibrozil—PPARA—skin of body—systemic scleroderma	0.00274	0.069	CbGeAlD
Gemfibrozil—PPARA—digestive system—systemic scleroderma	0.00219	0.0552	CbGeAlD
Gemfibrozil—PPARA—lung—systemic scleroderma	0.00183	0.0461	CbGeAlD
Gemfibrozil—SLCO1B1—digestive system—systemic scleroderma	0.0014	0.0352	CbGeAlD
Gemfibrozil—CYP2C19—digestive system—systemic scleroderma	0.000912	0.0229	CbGeAlD
Gemfibrozil—CYP1A2—digestive system—systemic scleroderma	0.000745	0.0187	CbGeAlD
Gemfibrozil—CYP2C9—digestive system—systemic scleroderma	0.000707	0.0178	CbGeAlD
Gemfibrozil—CYP1A2—lung—systemic scleroderma	0.000622	0.0156	CbGeAlD
Gemfibrozil—CYP3A4—digestive system—systemic scleroderma	0.000539	0.0136	CbGeAlD
Gemfibrozil—Confusional state—Mycophenolic acid—systemic scleroderma	0.000366	0.0013	CcSEcCtD
Gemfibrozil—Abdominal pain—Captopril—systemic scleroderma	0.000365	0.0013	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000364	0.00129	CcSEcCtD
Gemfibrozil—Oedema—Mycophenolic acid—systemic scleroderma	0.000363	0.00129	CcSEcCtD
Gemfibrozil—Nausea—Pentoxifylline—systemic scleroderma	0.000362	0.00129	CcSEcCtD
Gemfibrozil—Vertigo—Lisinopril—systemic scleroderma	0.00036	0.00128	CcSEcCtD
Gemfibrozil—Diarrhoea—Mometasone—systemic scleroderma	0.00036	0.00128	CcSEcCtD
Gemfibrozil—Syncope—Lisinopril—systemic scleroderma	0.00036	0.00128	CcSEcCtD
Gemfibrozil—Leukopenia—Lisinopril—systemic scleroderma	0.000359	0.00128	CcSEcCtD
Gemfibrozil—Shock—Mycophenolic acid—systemic scleroderma	0.000357	0.00127	CcSEcCtD
Gemfibrozil—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000357	0.00127	CcSEcCtD
Gemfibrozil—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000356	0.00127	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000356	0.00127	CcSEcCtD
Gemfibrozil—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00126	CcSEcCtD
Gemfibrozil—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000353	0.00126	CcSEcCtD
Gemfibrozil—Loss of consciousness—Lisinopril—systemic scleroderma	0.000352	0.00125	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00035	0.00125	CcSEcCtD
Gemfibrozil—Cough—Lisinopril—systemic scleroderma	0.00035	0.00124	CcSEcCtD
Gemfibrozil—Muscular weakness—Prednisone—systemic scleroderma	0.000349	0.00124	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000348	0.00124	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000347	0.00123	CcSEcCtD
Gemfibrozil—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00123	CcSEcCtD
Gemfibrozil—Tension—Mycophenolate mofetil—systemic scleroderma	0.000345	0.00123	CcSEcCtD
Gemfibrozil—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00122	CcSEcCtD
Gemfibrozil—Paraesthesia—Leflunomide—systemic scleroderma	0.000342	0.00122	CcSEcCtD
Gemfibrozil—Myalgia—Lisinopril—systemic scleroderma	0.000341	0.00121	CcSEcCtD
Gemfibrozil—Chest pain—Lisinopril—systemic scleroderma	0.000341	0.00121	CcSEcCtD
Gemfibrozil—Arthralgia—Lisinopril—systemic scleroderma	0.000341	0.00121	CcSEcCtD
Gemfibrozil—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00121	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000339	0.00121	CcSEcCtD
Gemfibrozil—Dyspepsia—Leflunomide—systemic scleroderma	0.000335	0.00119	CcSEcCtD
Gemfibrozil—Pancreatitis—Prednisone—systemic scleroderma	0.000335	0.00119	CcSEcCtD
Gemfibrozil—Vomiting—Mometasone—systemic scleroderma	0.000335	0.00119	CcSEcCtD
Gemfibrozil—Feeling abnormal—Azathioprine—systemic scleroderma	0.000332	0.00118	CcSEcCtD
Gemfibrozil—Rash—Mometasone—systemic scleroderma	0.000332	0.00118	CcSEcCtD
Gemfibrozil—Asthenia—Captopril—systemic scleroderma	0.000332	0.00118	CcSEcCtD
Gemfibrozil—Dermatitis—Mometasone—systemic scleroderma	0.000331	0.00118	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000331	0.00118	CcSEcCtD
Gemfibrozil—Confusional state—Lisinopril—systemic scleroderma	0.00033	0.00117	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00033	0.00117	CcSEcCtD
Gemfibrozil—Headache—Mometasone—systemic scleroderma	0.00033	0.00117	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000329	0.00117	CcSEcCtD
Gemfibrozil—Fatigue—Leflunomide—systemic scleroderma	0.000328	0.00117	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000327	0.00116	CcSEcCtD
Gemfibrozil—Oedema—Lisinopril—systemic scleroderma	0.000327	0.00116	CcSEcCtD
Gemfibrozil—Pruritus—Captopril—systemic scleroderma	0.000327	0.00116	CcSEcCtD
Gemfibrozil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000326	0.00116	CcSEcCtD
Gemfibrozil—Pain—Leflunomide—systemic scleroderma	0.000326	0.00116	CcSEcCtD
Gemfibrozil—Constipation—Leflunomide—systemic scleroderma	0.000326	0.00116	CcSEcCtD
Gemfibrozil—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00116	CcSEcCtD
Gemfibrozil—Somnolence—Mycophenolic acid—systemic scleroderma	0.000323	0.00115	CcSEcCtD
Gemfibrozil—Shock—Lisinopril—systemic scleroderma	0.000322	0.00115	CcSEcCtD
Gemfibrozil—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00114	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00032	0.00114	CcSEcCtD
Gemfibrozil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00032	0.00114	CcSEcCtD
Gemfibrozil—Abdominal pain—Azathioprine—systemic scleroderma	0.000319	0.00113	CcSEcCtD
Gemfibrozil—Skin disorder—Lisinopril—systemic scleroderma	0.000318	0.00113	CcSEcCtD
Gemfibrozil—Diarrhoea—Captopril—systemic scleroderma	0.000316	0.00112	CcSEcCtD
Gemfibrozil—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00112	CcSEcCtD
Gemfibrozil—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00112	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Prednisone—systemic scleroderma	0.000315	0.00112	CcSEcCtD
Gemfibrozil—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000314	0.00112	CcSEcCtD
Gemfibrozil—Feeling abnormal—Leflunomide—systemic scleroderma	0.000314	0.00112	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000314	0.00112	CcSEcCtD
Gemfibrozil—Fatigue—Mycophenolic acid—systemic scleroderma	0.000313	0.00111	CcSEcCtD
Gemfibrozil—Nausea—Mometasone—systemic scleroderma	0.000313	0.00111	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000311	0.00111	CcSEcCtD
Gemfibrozil—Pain—Mycophenolic acid—systemic scleroderma	0.000311	0.00111	CcSEcCtD
Gemfibrozil—Constipation—Mycophenolic acid—systemic scleroderma	0.000311	0.00111	CcSEcCtD
Gemfibrozil—Weight decreased—Prednisone—systemic scleroderma	0.000309	0.0011	CcSEcCtD
Gemfibrozil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000309	0.0011	CcSEcCtD
Gemfibrozil—Cough—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00109	CcSEcCtD
Gemfibrozil—Dizziness—Captopril—systemic scleroderma	0.000306	0.00109	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000305	0.00109	CcSEcCtD
Gemfibrozil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00108	CcSEcCtD
Gemfibrozil—Depression—Prednisone—systemic scleroderma	0.000304	0.00108	CcSEcCtD
Gemfibrozil—Urticaria—Leflunomide—systemic scleroderma	0.000303	0.00108	CcSEcCtD
Gemfibrozil—Abdominal pain—Leflunomide—systemic scleroderma	0.000301	0.00107	CcSEcCtD
Gemfibrozil—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000299	0.00107	CcSEcCtD
Gemfibrozil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00106	CcSEcCtD
Gemfibrozil—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00106	CcSEcCtD
Gemfibrozil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00106	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000299	0.00106	CcSEcCtD
Gemfibrozil—Breast disorder—Methotrexate—systemic scleroderma	0.000299	0.00106	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000298	0.00106	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000297	0.00106	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00106	CcSEcCtD
Gemfibrozil—Paraesthesia—Lisinopril—systemic scleroderma	0.000294	0.00105	CcSEcCtD
Gemfibrozil—Vomiting—Captopril—systemic scleroderma	0.000294	0.00105	CcSEcCtD
Gemfibrozil—Rash—Captopril—systemic scleroderma	0.000291	0.00104	CcSEcCtD
Gemfibrozil—Dermatitis—Captopril—systemic scleroderma	0.000291	0.00104	CcSEcCtD
Gemfibrozil—Somnolence—Lisinopril—systemic scleroderma	0.000291	0.00104	CcSEcCtD
Gemfibrozil—Headache—Captopril—systemic scleroderma	0.000289	0.00103	CcSEcCtD
Gemfibrozil—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000289	0.00103	CcSEcCtD
Gemfibrozil—Dyspepsia—Lisinopril—systemic scleroderma	0.000288	0.00102	CcSEcCtD
Gemfibrozil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000287	0.00102	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00102	CcSEcCtD
Gemfibrozil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00102	CcSEcCtD
Gemfibrozil—Eosinophilia—Methotrexate—systemic scleroderma	0.000283	0.00101	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000283	0.00101	CcSEcCtD
Gemfibrozil—Fatigue—Lisinopril—systemic scleroderma	0.000282	0.001	CcSEcCtD
Gemfibrozil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000282	0.001	CcSEcCtD
Gemfibrozil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000281	0.001	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000999	CcSEcCtD
Gemfibrozil—Pancreatitis—Methotrexate—systemic scleroderma	0.00028	0.000996	CcSEcCtD
Gemfibrozil—Pain—Lisinopril—systemic scleroderma	0.00028	0.000996	CcSEcCtD
Gemfibrozil—Constipation—Lisinopril—systemic scleroderma	0.00028	0.000996	CcSEcCtD
Gemfibrozil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000991	CcSEcCtD
Gemfibrozil—Diarrhoea—Azathioprine—systemic scleroderma	0.000276	0.000982	CcSEcCtD
Gemfibrozil—Nausea—Captopril—systemic scleroderma	0.000274	0.000977	CcSEcCtD
Gemfibrozil—Asthenia—Leflunomide—systemic scleroderma	0.000273	0.000972	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—systemic scleroderma	0.000271	0.000965	CcSEcCtD
Gemfibrozil—Feeling abnormal—Lisinopril—systemic scleroderma	0.00027	0.000959	CcSEcCtD
Gemfibrozil—Pruritus—Leflunomide—systemic scleroderma	0.000269	0.000959	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Prednisone—systemic scleroderma	0.000269	0.000956	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000268	0.000952	CcSEcCtD
Gemfibrozil—Dizziness—Azathioprine—systemic scleroderma	0.000267	0.000949	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000263	0.000936	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000929	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000261	0.000928	CcSEcCtD
Gemfibrozil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000261	0.000927	CcSEcCtD
Gemfibrozil—Diarrhoea—Leflunomide—systemic scleroderma	0.000261	0.000927	CcSEcCtD
Gemfibrozil—Urticaria—Lisinopril—systemic scleroderma	0.00026	0.000925	CcSEcCtD
Gemfibrozil—Abdominal pain—Lisinopril—systemic scleroderma	0.000259	0.00092	CcSEcCtD
Gemfibrozil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000916	CcSEcCtD
Gemfibrozil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000257	0.000914	CcSEcCtD
Gemfibrozil—Vomiting—Azathioprine—systemic scleroderma	0.000256	0.000912	CcSEcCtD
Gemfibrozil—Eye disorder—Prednisone—systemic scleroderma	0.000256	0.00091	CcSEcCtD
Gemfibrozil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000907	CcSEcCtD
Gemfibrozil—Rash—Azathioprine—systemic scleroderma	0.000254	0.000905	CcSEcCtD
Gemfibrozil—Dermatitis—Azathioprine—systemic scleroderma	0.000254	0.000904	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—systemic scleroderma	0.000254	0.000903	CcSEcCtD
Gemfibrozil—Headache—Azathioprine—systemic scleroderma	0.000253	0.000899	CcSEcCtD
Gemfibrozil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000898	CcSEcCtD
Gemfibrozil—Dizziness—Leflunomide—systemic scleroderma	0.000252	0.000896	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—systemic scleroderma	0.00025	0.000891	CcSEcCtD
Gemfibrozil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000249	0.000884	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000881	CcSEcCtD
Gemfibrozil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000872	CcSEcCtD
Gemfibrozil—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000872	CcSEcCtD
Gemfibrozil—Vomiting—Leflunomide—systemic scleroderma	0.000242	0.000861	CcSEcCtD
Gemfibrozil—Alopecia—Prednisone—systemic scleroderma	0.000242	0.00086	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000241	0.000857	CcSEcCtD
Gemfibrozil—Dizziness—Mycophenolic acid—systemic scleroderma	0.00024	0.000855	CcSEcCtD
Gemfibrozil—Rash—Leflunomide—systemic scleroderma	0.00024	0.000854	CcSEcCtD
Gemfibrozil—Dermatitis—Leflunomide—systemic scleroderma	0.00024	0.000854	CcSEcCtD
Gemfibrozil—Mental disorder—Prednisone—systemic scleroderma	0.00024	0.000853	CcSEcCtD
Gemfibrozil—Nausea—Azathioprine—systemic scleroderma	0.00024	0.000852	CcSEcCtD
Gemfibrozil—Headache—Leflunomide—systemic scleroderma	0.000239	0.000849	CcSEcCtD
Gemfibrozil—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000841	CcSEcCtD
Gemfibrozil—Asthenia—Lisinopril—systemic scleroderma	0.000235	0.000835	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000834	CcSEcCtD
Gemfibrozil—Pruritus—Lisinopril—systemic scleroderma	0.000232	0.000824	CcSEcCtD
Gemfibrozil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000231	0.000822	CcSEcCtD
Gemfibrozil—Rash—Mycophenolic acid—systemic scleroderma	0.000229	0.000815	CcSEcCtD
Gemfibrozil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000229	0.000814	CcSEcCtD
Gemfibrozil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000228	0.00081	CcSEcCtD
Gemfibrozil—Headache—Mycophenolic acid—systemic scleroderma	0.000228	0.00081	CcSEcCtD
Gemfibrozil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000806	CcSEcCtD
Gemfibrozil—Nausea—Leflunomide—systemic scleroderma	0.000226	0.000805	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisone—systemic scleroderma	0.000224	0.000798	CcSEcCtD
Gemfibrozil—Diarrhoea—Lisinopril—systemic scleroderma	0.000224	0.000797	CcSEcCtD
Gemfibrozil—Anaemia—Prednisone—systemic scleroderma	0.00022	0.000783	CcSEcCtD
Gemfibrozil—Angioedema—Prednisone—systemic scleroderma	0.000218	0.000774	CcSEcCtD
Gemfibrozil—Dizziness—Lisinopril—systemic scleroderma	0.000216	0.00077	CcSEcCtD
Gemfibrozil—Nausea—Mycophenolic acid—systemic scleroderma	0.000216	0.000768	CcSEcCtD
Gemfibrozil—Vertigo—Prednisone—systemic scleroderma	0.000214	0.000761	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—systemic scleroderma	0.000214	0.00076	CcSEcCtD
Gemfibrozil—Syncope—Prednisone—systemic scleroderma	0.000214	0.00076	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisone—systemic scleroderma	0.000209	0.000745	CcSEcCtD
Gemfibrozil—Vomiting—Lisinopril—systemic scleroderma	0.000208	0.00074	CcSEcCtD
Gemfibrozil—Rash—Lisinopril—systemic scleroderma	0.000206	0.000734	CcSEcCtD
Gemfibrozil—Convulsion—Prednisone—systemic scleroderma	0.000206	0.000734	CcSEcCtD
Gemfibrozil—Dermatitis—Lisinopril—systemic scleroderma	0.000206	0.000733	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000206	0.000733	CcSEcCtD
Gemfibrozil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000732	CcSEcCtD
Gemfibrozil—Headache—Lisinopril—systemic scleroderma	0.000205	0.000729	CcSEcCtD
Gemfibrozil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000722	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—systemic scleroderma	0.000203	0.000721	CcSEcCtD
Gemfibrozil—Arthralgia—Prednisone—systemic scleroderma	0.000203	0.000721	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—systemic scleroderma	0.000202	0.000719	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000201	0.000716	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—systemic scleroderma	0.0002	0.000713	CcSEcCtD
Gemfibrozil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000698	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—systemic scleroderma	0.000195	0.000693	CcSEcCtD
Gemfibrozil—Nausea—Lisinopril—systemic scleroderma	0.000194	0.000692	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—systemic scleroderma	0.000194	0.000691	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisone—systemic scleroderma	0.000194	0.000691	CcSEcCtD
Gemfibrozil—Shock—Prednisone—systemic scleroderma	0.000191	0.00068	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—systemic scleroderma	0.000191	0.000678	CcSEcCtD
Gemfibrozil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000675	CcSEcCtD
Gemfibrozil—Skin disorder—Prednisone—systemic scleroderma	0.000189	0.000672	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—systemic scleroderma	0.000188	0.000667	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—systemic scleroderma	0.000184	0.000654	CcSEcCtD
Gemfibrozil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000649	CcSEcCtD
Gemfibrozil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000643	CcSEcCtD
Gemfibrozil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000643	CcSEcCtD
Gemfibrozil—Headache—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000639	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—systemic scleroderma	0.000179	0.000636	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—systemic scleroderma	0.000178	0.000634	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000177	0.00063	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisone—systemic scleroderma	0.000175	0.000621	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—systemic scleroderma	0.000174	0.000618	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—systemic scleroderma	0.000172	0.000613	CcSEcCtD
Gemfibrozil—Dyspepsia—Prednisone—systemic scleroderma	0.000171	0.000609	CcSEcCtD
Gemfibrozil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000606	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—systemic scleroderma	0.000169	0.000603	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—systemic scleroderma	0.000169	0.000603	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—systemic scleroderma	0.000169	0.000603	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000168	0.000599	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—systemic scleroderma	0.000168	0.000596	CcSEcCtD
Gemfibrozil—Constipation—Prednisone—systemic scleroderma	0.000166	0.000591	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—systemic scleroderma	0.000164	0.000583	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000162	0.000578	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisone—systemic scleroderma	0.00016	0.00057	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—systemic scleroderma	0.000159	0.000567	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000159	0.000566	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000159	0.000565	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—systemic scleroderma	0.000158	0.000561	CcSEcCtD
Gemfibrozil—Urticaria—Prednisone—systemic scleroderma	0.000154	0.000549	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—systemic scleroderma	0.000154	0.000547	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000148	0.000526	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—systemic scleroderma	0.000146	0.000519	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—systemic scleroderma	0.000144	0.000514	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—systemic scleroderma	0.000143	0.000509	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00014	0.000499	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—systemic scleroderma	0.00014	0.000498	CcSEcCtD
Gemfibrozil—Asthenia—Prednisone—systemic scleroderma	0.000139	0.000496	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—systemic scleroderma	0.000139	0.000494	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—systemic scleroderma	0.000138	0.000489	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—systemic scleroderma	0.000134	0.000476	CcSEcCtD
Gemfibrozil—Diarrhoea—Prednisone—systemic scleroderma	0.000133	0.000473	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000133	0.000473	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—systemic scleroderma	0.000129	0.000459	CcSEcCtD
Gemfibrozil—Dizziness—Prednisone—systemic scleroderma	0.000129	0.000457	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—systemic scleroderma	0.000128	0.000457	CcSEcCtD
Gemfibrozil—Vomiting—Prednisone—systemic scleroderma	0.000124	0.00044	CcSEcCtD
Gemfibrozil—Rash—Prednisone—systemic scleroderma	0.000123	0.000436	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—systemic scleroderma	0.000122	0.000436	CcSEcCtD
Gemfibrozil—Headache—Prednisone—systemic scleroderma	0.000122	0.000433	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—systemic scleroderma	0.000117	0.000415	CcSEcCtD
Gemfibrozil—Nausea—Prednisone—systemic scleroderma	0.000115	0.000411	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—systemic scleroderma	0.000115	0.000409	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—systemic scleroderma	0.000111	0.000395	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—systemic scleroderma	0.000107	0.000382	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—systemic scleroderma	0.000103	0.000367	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—systemic scleroderma	0.000102	0.000364	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—systemic scleroderma	0.000102	0.000364	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—systemic scleroderma	0.000102	0.000362	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—systemic scleroderma	9.65e-05	0.000343	CcSEcCtD
